AbstractHepatocellular carcinoma (HCC) remains a global health challenge. Novel treatment modalities are urgently needed to extend the overall survival of patients. The liver plays an immunomodulatory function due to its unique physiological structural characteristics. Therefore, following surgical resection and radiotherapy, immunotherapy regimens have shown great potential in the treatment of hepatocellular carcinoma. Adoptive cell immunotherapy is rapidly developing in the treatment of hepatocellular carcinoma. In this review, we summarize the latest research on adoptive immunotherapy for hepatocellular carcinoma. The focus is on chimeric antigen receptor (CAR)‐T cells and T cell receptor (TCR) engineered T cells. Then tumour‐infiltrating lymphocytes (TILs), natural killer (NK) cells, cytokine‐induced killer (CIK) cells, and macrophages are briefly discussed. The main overview of the application and challenges of adoptive immunotherapy in hepatocellular carcinoma. It aims to provide the reader with a comprehensive understanding of the current status of HCC adoptive immunotherapy and offers some strategies. We hope to provide new ideas for the clinical treatment of hepatocellular carcinoma.

More from our Archive

• DOI: 10.1111/all.15807 2023

  Global, regional, and national burden of allergic disorders and their risk factors in 204 countries and territories, from 1990 to 2019: A systematic analysis for the Global Burden of Disease Study 2019

  Youn Ho Shin, Jimin Hwang, Rosie Kwon, Seung Won Lee, Min Seo Kim, Jae Il Shin, Dong Keon Yon,

• DOI: 10.3390/vaccines11071217 2023

  Artificial Intelligence and Public Health: Evaluating ChatGPT Responses to Vaccination Myths and Misconceptions

  Giovanna Deiana, Marco Dettori, Antonella Arghittu, Antonio Azara, Giovanni Gabutti, Paolo Castiglia

• DOI: 10.1111/all.15801 2023

  Prevalence estimates of eight big food allergies in Europe: Updated systematic review and meta‐analysis

  Giulia C. I. Spolidoro, Mohamed Mustafa Ali, Yohannes Tesfaye Amera, Sungkutu Nyassi, Daniil Lisik, Athina Ioannidou, Graciela Rovner, Ekaterina Khaleva, Carina Venter, Ronald van Ree, Margitta Worm, Berber Vlieg‐Boerstra, Aziz Sheikh, Antonella Muraro, Graham Roberts, Bright I. Nwaru

• DOI: 10.1182/blood.2022018818 2023

  Detailed safety profile of acalabrutinib vs ibrutinib in previously treated chronic lymphocytic leukemia in the ELEVATE-RR trial

  John F. Seymour, John C. Byrd, Paolo Ghia, Arnon P. Kater, Asher Chanan-Khan, Richard R. Furman, Susan O’Brien, Jennifer R. Brown, Talha Munir, Anthony Mato, Stephan Stilgenbauer, Naghmana Bajwa, Paulo Miranda, Kara Higgins, Ellie John, Marianne de Borja, Wojciech Jurczak, Jennifer A. Woyach

• DOI: 10.1111/imr.13235 2023

  Ferroptosis in immunostimulation and immunosuppression

  Daolin Tang, Guido Kroemer, Rui Kang

• DOI: 10.1002/art.42645 2023

  Association Between Severe Nonadherence to Hydroxychloroquine and Systemic Lupus Erythematosus Flares, Damage, and Mortality in 660 Patients From the <scp>SLICC</scp> Inception Cohort

  Yann Nguyen, Benoît Blanchet, Murray B. Urowitz, John G. Hanly, Caroline Gordon, Sang‐Cheol Bae, Juanita Romero‐Diaz, Jorge Sanchez‐Guerrero, Ann E. Clarke, Sasha Bernatsky, Daniel J. Wallace, David A. Isenberg, Anisur Rahman, Joan T. Merrill, Paul R. Fortin, Dafna D. Gladman, Ian N. Bruce, Michelle Petri, Ellen M. Ginzler, Mary Anne Dooley, Rosalind Ramsey‐Goldman, Susan Manzi, Andreas Jönsen, Graciela S. Alarcón, Ronald F. Van Vollenhoven, Cynthia Aranow, Véronique Le Guern, Meggan Mackay, Guillermo Ruiz‐Irastorza, S. Sam Lim, Murat Inanc, Kenneth C. Kalunian, Søren Jacobsen, Christine A. Peschken, Diane L. Kamen, Anca Askanase, Jill Buyon, Nathalie Costedoat‐Chalumeau

• DOI: 10.1126/sciimmunol.abo4365 2023

  A three-stage developmental pathway for human Vγ9Vδ2 T cells within the postnatal thymus

  Louis Perriman, Naeimeh Tavakolinia, Sedigheh Jalali, Shuo Li, Peter F. Hickey, Daniela Amann-Zalcenstein, William Wing Ho Ho, Tracey M. Baldwin, Adam T. Piers, Igor E. Konstantinov, Jeremy Anderson, Edouard G. Stanley, Paul V. Licciardi, George Kannourakis, Shalin H. Naik, Hui-Fern Koay, Laura K. Mackay, Stuart P. Berzins, Daniel G. Pellicci

• DOI: 10.1126/sciimmunol.add4817 2023

  Restoring tumor immunogenicity with dendritic cell reprogramming

  Olga Zimmermannova, Alexandra G. Ferreira, Ervin Ascic, Marta Velasco Santiago, Ilia Kurochkin, Morten Hansen, Özcan Met, Inês Caiado, Ilja E. Shapiro, Justine Michaux, Marion Humbert, Diego Soto-Cabrera, Hreinn Benonisson, Rita Silvério-Alves, David Gomez-Jimenez, Carina Bernardo, Monika Bauden, Roland Andersson, Mattias Höglund, Kenichi Miharada, Yukio Nakamura, Stephanie Hugues, Lennart Greiff, Malin Lindstedt, Fábio F. Rosa, Cristiana F. Pires, Michal Bassani-Sternberg, Inge Marie Svane, Carlos-Filipe Pereira

• DOI: 10.1111/pai.13984 2023

  Dietary prevention strategies for childhood asthma

  Nicklas Brustad, Klaus Bønnelykke, Bo Chawes

• DOI: 10.3390/vaccines11071181 2023

  The End or a New Era of Development of SARS-CoV-2 Virus: Genetic Variants Responsible for Severe COVID-19 and Clinical Efficacy of the Most Commonly Used Vaccines in Clinical Practice

  Dimitrina Miteva, Meglena Kitanova, Hristiana Batselova, Snezhina Lazova, Lyubomir Chervenkov, Monika Peshevska-Sekulovska, Metodija Sekulovski, Milena Gulinac, Georgi V. Vasilev, Luchesar Tomov, Tsvetelina Velikova